UBS O'Connor »

Pyxis Oncology shares owned by UBS O'Connor

Quarter-by-quarter ownership of Pyxis Oncology (PYXS) shares owned by UBS O'Connor from 13F filings

Historical chart of UBS O'Connor investment in Pyxis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Pyxis Oncology held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pyxis Oncology by UBS O'Connor

Quarter filed Position value Share count Share price at filing
2024-12-31 $228k 146k 1.56

More positions owned by UBS O'Connor

Verona Pha Spons (VRNA)
Mr Cooper Group
Spirit Aer Comcl (SPR)
NVIDIA Corporation (NVDA)
Snowflake Note1 (Principal)
Peloton In Note2 (Principal)
Halozyme T Note0 (Principal)
Alliant Energy Corporation (LNT)
Draftkings Note3 (Principal)
Southern C Note4 (Principal)
Entergy Corporation (ETR)
Southern Company (SO)
Packaging Corporation of America (PKG)
Duke Energ Note4 (Principal)
American W Note3 (Principal)

View all positions for UBS O'Connor

Top funds holding Pyxis Oncology

Pfizer
Laurion Capital Management
Tang Capital Management
Vanguard Group
Perceptive Advisors
Palo Alto Investors
Millennium Management
Stempoint Capital
BlackRock
Renaissance Technologies
Geode Capital Management
683 Capital Management
Driehaus Capital Management
UBS Group
Citadel Advisors

View all funds holding Pyxis Oncology